Cytogenetic risk doesn't seem to explain the disparity in mortality of Black vs White patients, a study across 10 clinical ...

Xelafaslatide was safe and well tolerated at all evaluated doses, with the potential to reduce GA lesion growth and improve ...

The production of new nurses to help address national nursing shortages starts with the educational pipeline. However, ...

Medicenna Therapeutics Corp ( ($TSE:MDNA) ) has shared an update. Medicenna Therapeutics announced a live webinar to discuss updated clinical data ...

ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of ...

Discover why Terns Pharmaceuticals, Inc. stock is up 770% YTD with strong CML drug data and major upcoming milestones. Click ...

UAE, Dubai: The Emirates Drug Establishment (EDE), in collaboration with the Drug Information Association (DIA), Middle East ...

UNIONDALE, NY / ACCESS Newswire / December 8, 2025 / Marquis Who’s Who, the trusted biographical authority documenting ...

Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders ...

A retrospective real-world study strengthens evidence that early, sustained treatment with the antiamyloid lecanemab can slow ...

In an updated report, Wave Life Sciences Ltd (NASDAQ:WVE) said that enrolled patients who took 240 mg of its drug candidate, ...

MELBOURNE, Australia, December 5, 2025 (EZ Newswire) -- iNGENū CRO, a global contract research organization, has set out the ...